“Real world survey” of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients.
Ji-Bing Chen, Xiao-Feng Kong, You-Yong Lv, Shu-Cun Qin, Xue-Jun Sun, Feng Mu, Tian-Yu Lu, Ke-Cheng Xu · Medical gas research · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 82 patients with stage III and IV cancer treated with hydrogen inhalation using the "real world evidence" method, of the 58 cases with one or more abnormal tumor markers elevated, the markers were decreased at 13-45 days (median 23 days) after hydrogen inhalation in 36.2%.
What the Researchers Studied
82 patients with stage III and IV cancer treated with hydrogen inhalation using the "real world evidence" method.
How the Study Was Conducted
Human clinical study
How Molecular Hydrogen Was Used
The researchers conducted a prospective follow-up study of 82 patients with stage III and IV cancer treated with hydrogen inhalation using the "real world evidence" method.
What the Researchers Found
Of the 58 cases with one or more abnormal tumor markers elevated, the markers were decreased at 13-45 days (median 23 days) after hydrogen inhalation in 36.2%.